Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Parent Market Analysis: Orthopedic Procedures Market
3.2. Key Drivers
3.2.1. Bone And Joint-Related Diseases In The Geriatric Population
3.2.2. Growing Number Of Sport Injuries
3.2.3. Prevalence Of Musculoskeletal Disorders
3.3. Key Restraints
3.3.1. High Costs Of Joint Repair Therapies
3.3.2. Side Effects Associated With Joint Repair Injections

4. Key Analytics
4.1. Impact Of Covid-19 On Joint Pain Injections Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entry
4.3.5. Industry Rivalry
4.4. Key Buying Criteria
4.5. Opportunity Matrix
4.6. Vendor Landscape

5. Market By Joint Type
5.1. Knee
5.2. Shoulder And Elbow
5.3. Hip
5.4. Foot And Ankle
5.5. Other Joint Types

6. Market By Injection Type
6.1. Hyaluronic Acid
6.2. Corticosteroid
6.3. Other Drugs

7. Market By Distribution Channel
7.1. Hospitals Pharmacies
7.2. Retail Pharmacies
7.3. Other Distribution Channels

8. Geographical Analysis
8.1. North America
8.1.1. Market Size & Estimates
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. United States
8.1.5.2. Canada

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions, Announcements, And Divestitures
9.2. Company Profiles
9.2.1. Allergan Plc (Acquired By Abbvie)
9.2.2. Anika Therapeutics Inc
9.2.3. Bioventus Inc
9.2.4. Chugai Pharmaceutical
9.2.5. Ferring Pharmaceuticals
9.2.6. Fidia Pharma Usa Inc
9.2.7. Flexion Therapeutics Inc
9.2.8. Orthogenrx Inc
9.2.9. Pfizer Inc
9.2.10. Sanofi
9.2.11. Seikagaku Corporation
9.2.12. Smith & Nephew Plc
9.2.13. Teva Pharmaceutical Industries Limited
9.2.14. Zimmer Biomet Holdings



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: North America Joint Pain Injections Market, By Joint Type, In 2021
Figure 6: North America Joint Pain Injections Market, By Knee, 2022-2030 (In $ Million)
Figure 7: North America Joint Pain Injections Market, By Shoulder And Elbow, 2022-2030 (In $ Million)
Figure 8: North America Joint Pain Injections Market, By Hip, 2022-2030 (In $ Million)
Figure 9: North America Joint Pain Injections Market, By Foot And Ankle, 2022-2030 (In $ Million)
Figure 10: North America Joint Pain Injections Market, By Other Joint Types, 2022-2030 (In $ Million)
Figure 11: North America Joint Pain Injections Market, By Injection Type, In 2021
Figure 12: North America Joint Pain Injections Market, By Hyaluronic Acid, 2022-2030 (In $ Million)
Figure 13: North America Joint Pain Injections Market, By Corticosteroid, 2022-2030 (In $ Million)
Figure 14: North America Joint Pain Injections Market, By Other Drugs, 2022-2030 (In $ Million)
Figure 15: North America Joint Pain Injections Market, By Distribution Channel, In 2021
Figure 16: North America Joint Pain Injections Market, By Hospitals Pharmacies, 2022-2030 (In $ Million)
Figure 17: North America Joint Pain Injections Market, By Retail Pharmacies, 2022-2030 (In $ Million)
Figure 18: North America Joint Pain Injections Market, By Other Distribution Channels, 2022-2030 (In $ Million)
Figure 19: North America Joint Pain Injections Market, Country Outlook, 2021 & 2030 (In %)
Figure 20: United States Joint Pain Injections Market, 2022-2030 (In $ Million)
Figure 21: Canada Joint Pain Injections Market, 2022-2030 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - JOINT PAIN INJECTIONS
TABLE 2: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 4: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: LEADING PLAYERS OPERATING IN NORTH AMERICA JOINT PAIN INJECTIONS MARKET
TABLE 11: LIST OF MERGERS & ACQUISITIONS
TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 14: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES